‘Why do we value a Mars bar more than life-saving medicine?’ Sandoz CEO calls for level playing field with cheap Chinese antibiotics 

Feed excerpt — reported by Fortune

The Swiss pharmaceutical giant operates one of the last penicillin plants in Europe—losing it would raise new security and sovereignty challenges, says CEO Richard Saynor.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Fortune →

View MAP Context →